Phase II, Randomized, Double-blind, Controlled Clinical Trial Evaluating the Efficacy and Safety of Plasma From Patients Cured of COVID-19 Compared to the Best Available Therapy in Subjects With SARS-CoV-2 Pneumonia

Camacho-Ortiz et al., NCT04358783, COP-COVID-19, NCT04358783, May 2021
31 patient convalescent plasma late treatment RCT with results not reported over 5 years after completion.
29 convalescent plasma RCTs have results missing long after expected1-29
The trials report a total of 3,534 patients, with 15 trials having actual enrollment of 1,143, and the remainder estimated.
Camacho-Ortiz et al., 1 May 2021, Double Blind Randomized Controlled Trial, Mexico, trial NCT04358783 (history) (COP-COVID-19).
Late treatment
is less effective